All Stories

  1. Molecular fingerprints of drug-resistant epilepsy identified through liquid biopsy profiling

    Article • Drug Discovery Today, May 2026, Elsevier

    Professor Stergios Boussios

  2. The Current Landscape of Artificial Intelligence in Positron Emission Tomography (PET) Imaging Across the Cancer Continuum

    Article • Journal of Clinical Medicine, March 2026, MDPI AG

    Professor Stergios Boussios

  3. Genetically Optimized Modular Neural Networks for Precision Lung Cancer Diagnosis: Exploratory Study of Novel Approach

    Article • Cancer Diagnosis & Prognosis, March 2026, International Institute of Anticancer Research

    Professor Stergios Boussios

  4. Coronavirus disease 2019-associated mucormycosis and cytomegalovirus infection: a case report

    Article • Journal of Medical Case Reports, January 2026, Springer Science + Business Media

    Professor Stergios Boussios

  5. A multi-modal approach for decision making in bladder cancer

    Article • Nature Reviews Urology, January 2026, Springer Science + Business Media

    Professor Stergios Boussios

  6. Unlocking precision: Bispecific T cell engagers and the next frontier in uro-oncology

    Article • Critical Reviews in Oncology/Hematology, January 2026, Elsevier

    Professor Stergios Boussios

  7. Idiopathic Inflammatory Myopathy With Normal Creatine Kinase Levels in an Elderly Patient: A Diagnostic Challenge

    Article • Cureus, December 2025, Springer Science + Business Media

    Professor Stergios Boussios

  8. Redefining Chemotherapy-Related Headaches: From Pathobiology to Differential Diagnosis and Management

    Article • International Journal of Molecular Sciences, December 2025, MDPI AG

    Professor Stergios Boussios

  9. From Crisis to Cancer: Diabetic Ketoacidosis Unmasking a Malignancy of Unknown Origin

    Article • Cureus, December 2025, Springer Science + Business Media

    Professor Stergios Boussios

  10. Cancer Reversion Therapy: Prospects, Progress and Future Directions

    Article • Current Issues in Molecular Biology, December 2025, MDPI AG

    Professor Stergios Boussios

  11. Efficacy of ketogenic metabolic therapy as an adjuvant to the current standard of care in the treatment of glioblastoma: A systematic review of clinical trials

    Article • Medical Oncology, December 2025, Springer Science + Business Media

    Professor Stergios Boussios

  12. Molecular engines driving biogenesis, trafficking and release of exosomes: SNARE proteins

    Article • Extracellular Vesicle, December 2025, Elsevier

    Professor Stergios Boussios

  13. The risk of lung cancer from vaping or e-cigarette usage: a systematic review

    Article • ESMO Open, December 2025, Elsevier

    Professor Stergios Boussios

  14. Fatal Myocarditis Following Adjuvant Immunotherapy: A Case Report and Literature Review

    Article • International Journal of Molecular Sciences, December 2025, MDPI AG

    Professor Stergios Boussios

  15. Resolution of Persistent Fever and Systemic Inflammation in a Metastatic Gastrointestinal Stromal Tumour (GIST) With Imatinib

    Article • Cureus, November 2025, Springer Science + Business Media

    Professor Stergios Boussios

  16. Advancing circular economy practices in radiography: a narrative review of sustainable medical imaging

    Article • Translational Cancer Research, November 2025, AME Publishing Company

    Professor Stergios Boussios

  17. Therapeutic opportunities in EBV-positive gastric cancer subtypes

    Article • Therapeutic Advances in Medical Oncology, November 2025, SAGE Publications

    Professor Stergios Boussios

  18. SKP2 at the crossroads of proliferation and immune evasion: a new target in the tumor microenvironment

    Article • Precision Clinical Medicine, October 2025, Oxford University Press (OUP)

    Professor Stergios Boussios

  19. Smart Nanomedicines for Neurodegenerative Diseases: Empowering New Therapies with Molecular Imaging and Artificial Intelligence

    Article • Molecular Diagnosis & Therapy, October 2025, Springer Science + Business Media

    Professor Stergios Boussios

  20. Enhancing home rehabilitation through AI-driven virtual assistants: a narrative review

    Article • Annals of Translational Medicine, October 2025, AME Publishing Company

    Professor Stergios Boussios

  21. Generative artificial intelligence in predictive analysis of diabetes and its complications: a narrative review

    Article • Annals of Translational Medicine, October 2025, AME Publishing Company

    Professor Stergios Boussios

  22. Smart emergency care: a narrative review of predictive machine learning models

    Article • Annals of Translational Medicine, October 2025, AME Publishing Company

    Professor Stergios Boussios

  23. Comparative Analysis of Large Language Models in Dermatological Diagnosis: An Evaluation of Diagnostic Accuracy

    Article • Cureus, September 2025, Springer Science + Business Media

    Professor Stergios Boussios

  24. The evolution of targeted intra operative radiotherapy in early breast cancer

    Article • Journal of Cancer Research and Clinical Oncology, September 2025, Springer Science + Business Media

    Professor Stergios Boussios

  25. The landscape of conventional and artificial intelligence-based clinical prediction models in non-small-cell lung cancer: from development to real-world validation

    Article • ESMO Open, September 2025, Elsevier

    Professor Stergios Boussios

  26. Agnostic Biomarkers and Molecular Signatures in Colorectal Cancer—Guiding Chemotherapy and Predicting Response

    Article • Biomedicines, August 2025, MDPI AG

    Professor Stergios Boussios

  27. Immune Organoids: A Review of Their Applications in Cancer and Autoimmune Disease Immunotherapy

    Article • Current Issues in Molecular Biology, August 2025, MDPI AG

    Professor Stergios Boussios

  28. Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol

    Article • The Lancet Oncology, August 2025, Elsevier

    Professor Stergios Boussios

  29. Enhancing Parkinson’s disease prediction using meta-heuristic optimized machine learning models

    Article • Personalized Medicine, July 2025, Taylor & Francis

    Professor Stergios Boussios

  30. Evaluating AI adoption in healthcare: Insights from the information governance professionals in the United Kingdom

    Article • International Journal of Medical Informatics, July 2025, Elsevier

    Professor Stergios Boussios

  31. The Impact of AI-Driven Chatbot Assistance on Protocol Development and Clinical Research Engagement: An Implementation Report

    Article • Journal of Personalized Medicine, June 2025, MDPI AG

    Professor Stergios Boussios

  32. Stacked Ensemble Learning for Classification of Parkinson’s Disease Using Telemonitoring Vocal Features

    Article • Diagnostics, June 2025, MDPI AG

    Professor Stergios Boussios

  33. Urban Microclimates and Their Relationship with Social Isolation: A Review

    Article • International Journal of Environmental Research and Public Health, June 2025, MDPI AG

    Professor Stergios Boussios

  34. Molecularly directed therapy in cancers of unknown primary: A systematic review and meta-analysis

    Article • European Journal of Cancer, June 2025, Elsevier

    Professor Stergios Boussios

  35. Pathobiology and Molecular Pathways Implicated in Osteosarcoma Lung Metastasis: A Scoping Review

    Article • Technology in Cancer Research & Treatment, June 2025, SAGE Publications

    Professor Stergios Boussios

  36. Reversing Epigenetic Dysregulation in Neurodegenerative Diseases: Mechanistic and Therapeutic Considerations

    Article • International Journal of Molecular Sciences, May 2025, MDPI AG

    Professor Stergios Boussios

  37. Disentangling the Gordian Knot of parasympathetic innervations in arthritic joint

    Article • Neuroscience, May 2025, Elsevier

    Professor Stergios Boussios

  38. AI-Driven Advancements in Orthodontics for Precision and Patient Outcomes

    Article • Dentistry Journal, April 2025, MDPI AG

    Professor Stergios Boussios

  39. The current landscape of artificial intelligence in computational histopathology for cancer diagnosis

    Article • Discover Oncology, April 2025, Springer Science + Business Media

    Professor Stergios Boussios

  40. Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

    Article • JAMA Oncology, April 2025, American Medical Association (AMA)

    Professor Stergios Boussios

  41. Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment

    Article • Cancer Letters, April 2025, Elsevier

    Professor Stergios Boussios

  42. AI-Driven Advances in Low-Dose Imaging and Enhancement—A Review

    Article • Diagnostics, March 2025, MDPI AG

    Professor Stergios Boussios

  43. Spinal MRI in Patients with Suspected Metastatic Spinal Cord Compression: A Quality Improvement Audit in a District General Hospital in Kent, UK

    Article • International Journal of Environmental Research and Public Health, March 2025, MDPI AG

    Professor Stergios Boussios

  44. Diagnosis and Treatment of Gestational Non-Epithelial Ovarian Cancer: A Systematic Review

    Article • Anticancer Research, March 2025, International Institute of Anticancer Research

    Professor Stergios Boussios

  45. Male Breast Cancer: A Single Institutional Clinicopathological Profiling

    Article • Anticancer Research, March 2025, International Institute of Anticancer Research

    Professor Stergios Boussios

  46. Enhancing Ophthalmic Diagnosis and Treatment with Artificial Intelligence

    Article • Medicina, February 2025, MDPI AG

    Professor Stergios Boussios

  47. Precision oncology through next generation sequencing in hepatocellular carcinoma

    Article • Heliyon, February 2025, Elsevier

    Professor Stergios Boussios

  48. Spotlight on Lung Cancer Disparities in India

    Article • JCO Global Oncology, February 2025, American Society of Clinical Oncology (ASCO)

    Professor Stergios Boussios

  49. Molecular biomarkers of glial activation and injury in epilepsy

    Article • Drug Discovery Today, February 2025, Elsevier

    Professor Stergios Boussios

  50. Integrating AI into Cancer Immunotherapy—A Narrative Review of Current Applications and Future Directions

    Article • Diseases, January 2025, MDPI AG

    Professor Stergios Boussios

  51. Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response

    Article • International Journal of Molecular Sciences, January 2025, MDPI AG

    Professor Stergios Boussios

  52. Molecular Biology of Cancer—Interplay of Malignant Cells with Emerging Therapies

    Article • International Journal of Molecular Sciences, December 2024, MDPI AG

    Professor Stergios Boussios

  53. Construction of a prognostic survival model with tumor immune-related genes for breast cancer

    Article • Translational Cancer Research, December 2024, AME Publishing Company

    Professor Stergios Boussios

  54. An overview of immune checkpoint inhibitor toxicities in bladder cancer

    Article • Toxicology Reports, December 2024, Elsevier

    Professor Stergios Boussios

  55. An orthogonal approach for analysis of underivatized steroid hormones using ultrahigh performance supercritical fluid chromatography-mass spectrometry (UHPSFC-MS)

    Article • Acta Neurovegetativa, November 2024, Springer Science + Business Media

    Professor Stergios Boussios

  56. AI-Guided Cancer Therapy for Patients with Coexisting Migraines

    Article • Cancers, October 2024, MDPI AG

    Professor Stergios Boussios

  57. Artificial Intelligence – Guided Cancer Therapy for Patients with Migraine Comorbidities

    Article • October 2024, MDPI AG

    Professor Stergios Boussios

  58. Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer

    Article • ecancermedicalscience, September 2024, Cancer Intelligence

    Professor Stergios Boussios

  59. Paediatric Anatomical Models in Radiotherapy Applications

    Article • Clinical Oncology, September 2024, Elsevier

    Professor Stergios Boussios

  60. Applying whole-genome and whole-exome sequencing in breast cancer: a review of the landscape

    Article • Breast Cancer, August 2024, Springer Science + Business Media

    Professor Stergios Boussios

  61. Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2024, New England Journal of Medicine (NEJM/MMS)

    Professor Stergios Boussios

  62. Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape

    Article • Current Oncology Reports, April 2024, Springer Science + Business Media

    Professor Stergios Boussios

  63. lncRNA Biomarkers of Glioblastoma Multiforme

    Article • Biomedicines, April 2024, MDPI AG

    Professor Stergios Boussios

  64. Large Language Models in Oncology: Revolution or Cause for Concern?

    Article • Current Oncology, March 2024, MDPI AG

    Professor Stergios Boussios

  65. The Application of Radiomics and AI to Molecular Imaging for Prostate Cancer

    Article • Journal of Personalized Medicine, March 2024, MDPI AG

    Professor Stergios Boussios

  66. A novel PD-1/PD-L1 pathway-related seven-gene signature for the development and validation of the prognosis prediction model for breast cancer

    Article • Translational Cancer Research, March 2024, AME Publishing Company

    Professor Stergios Boussios

  67. A rare case of metaplastic breast carcinoma from India: Towards precision oncology

    Article • Cancer Reports, February 2024, Wiley

    Professor Stergios Boussios

  68. Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma – A Meta-analysis

    Article • Anticancer Research, February 2024, International Institute of Anticancer Research

    Professor Stergios Boussios

  69. Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4

    Article • Therapeutic Advances in Medical Oncology, January 2024, SAGE Publications

    Professor Stergios Boussios

  70. Exosomes in Renal Cell Cancer: Diagnostic and Therapeutic Nanovehicles

    Article • Technology in Cancer Research & Treatment, January 2024, SAGE Publications

    Professor Stergios Boussios

  71. Stage 3 N2 Lung Cancer: A Multidisciplinary Therapeutic Conundrum

    Article • Current Oncology Reports, January 2024, Springer Science + Business Media

    Professor Stergios Boussios

  72. Medical oncology: challenges in 2022

    Article • Annals of Palliative Medicine, January 2024, AME Publishing Company

    Professor Stergios Boussios

  73. Frontiers of Molecular Biology of Cancer

    Article • International Journal of Molecular Sciences, December 2023, MDPI AG

    Professor Stergios Boussios

  74. Immune checkpoint inhibitors in patients with cancers of unknown primary

    Article • European Journal of Cancer, December 2023, Elsevier

    Professor Stergios Boussios

  75. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness

    Article • Translational Cancer Research, December 2023, AME Publishing Company

    Professor Stergios Boussios

  76. Frontiers of Ovarian Carcinosarcoma

    Article • Current Treatment Options in Oncology, November 2023, Springer Science + Business Media

    Professor Stergios Boussios

  77. COVID-19 Associated Mucormycosis and Cytomegalovirus Infection – A Case Report

    Article • November 2023, MDPI AG

    Professor Stergios Boussios

  78. Renal Cell Cancer – Insights in Drug Resistance Mechanisms

    Article • Anticancer Research, November 2023, International Institute of Anticancer Research

    Professor Stergios Boussios

  79. The integration of palliative care with oncology: the path ahead

    Article • Annals of Palliative Medicine, November 2023, AME Publishing Company

    Professor Stergios Boussios

  80. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine

    Article • Current Issues in Molecular Biology, October 2023, MDPI AG

    Professor Stergios Boussios

  81. Exosomes in the Diagnosis and Treatment of Renal Cell Cancer

    Article • International Journal of Molecular Sciences, September 2023, MDPI AG

    Professor Stergios Boussios

  82. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study

    Article • Cancers, September 2023, MDPI AG

    Professor Stergios Boussios

  83. Gestational Renal Cell Cancer – An Update

    Article • Anticancer Research, August 2023, International Institute of Anticancer Research

    Professor Stergios Boussios

  84. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities

    Article • International Journal of Molecular Sciences, August 2023, MDPI AG

    Professor Stergios Boussios

  85. Re: Pain and Health-related Quality of Life with Olaparib Versus Physician’s Choice of Next-generation Hormonal Drug in Patients with Metastatic Castration-resistant Prostate Cancer with Homologous Recombination Repair Gene Alterations (PROfound): An O...

    Article • European Urology, August 2023, Elsevier

    Professor Stergios Boussios

  86. Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer – a Retrospective UK Single-Center Study

    Article • July 2023, MDPI AG

    Professor Stergios Boussios

  87. Emerging Hallmarks of the Tumour Microenvironment of Gliomas and the Interplay with Immunotherapy

    Article • July 2023, MDPI AG

    Professor Stergios Boussios

  88. Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors

    Article • Current Cancer Drug Targets, July 2023, Bentham Science Publishers

    Professor Stergios Boussios

  89. Advances in adoptive T-cell therapy for metastatic melanoma

    Article • Current Research in Translational Medicine, July 2023, Elsevier

    Professor Stergios Boussios

  90. Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours

    Article • International Journal of Environmental Research and Public Health, June 2023, MDPI AG

    Professor Stergios Boussios

  91. Impact of COVID-19 on cancer services and patients’ outcomes: a retrospective single-center study

    Article • Annals of Translational Medicine, June 2023, AME Publishing Company

    Professor Stergios Boussios

  92. State-of-the-Art Molecular Oncology in UK

    Article • International Journal of Molecular Sciences, May 2023, MDPI AG

    Professor Stergios Boussios

  93. Posterior Reversible Encephalopathy Syndrome after Pazopanib Therapy

    Article • Diseases, May 2023, MDPI AG

    Professor Stergios Boussios

  94. Clinico-Pathological Factors Determining Recurrence of Phyllodes Tumors of the Breast: The 25-Year Experience at a Tertiary Cancer Centre

    Article • Journal of Personalized Medicine, May 2023, MDPI AG

    Professor Stergios Boussios

  95. Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

    Article • The Lancet Oncology, May 2023, Elsevier

    Professor Stergios Boussios

  96. Prostate cancer—what about oligometastatic disease and stereotactic ablative radiotherapy?—a narrative review

    Article • Annals of Palliative Medicine, May 2023, AME Publishing Company

    Professor Stergios Boussios

  97. From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Professor Stergios Boussios

  98. Constrictive Pericarditis–A Cloak Camouflaging Lymphoma

    Article • Hematology Reports, March 2023, MDPI AG

    Professor Stergios Boussios

  99. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

    Article • The Lancet Oncology, March 2023, Elsevier

    Professor Stergios Boussios

  100. Aberrations of DNA Repair Pathways in Prostate Cancer—The State of the Art

    Article • International Journal of Molecular Sciences, February 2023, MDPI AG

    Professor Stergios Boussios

  101. HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK

    Article • Pathogens, February 2023, MDPI AG

    Professor Stergios Boussios

  102. Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer

    Article • Therapeutic Advances in Medical Oncology, January 2023, SAGE Publications

    Professor Stergios Boussios

  103. Efficacy and Safety of COVID-19 Vaccines—An Update

    Article • Diseases, November 2022, MDPI AG

    Professor Stergios Boussios

  104. A Primary Mediastinal Monophasic Spindle-Cell Synovial Sarcoma with Superior Venacaval Obstruction

    Article • Diseases, November 2022, MDPI AG

    Professor Stergios Boussios

  105. Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy

    Article • International Journal of Environmental Research and Public Health, September 2022, MDPI AG

    Professor Stergios Boussios

  106. Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes

    Article • Journal of Personalized Medicine, September 2022, MDPI AG

    Professor Stergios Boussios

  107. Chromosomal instability in cancers of unknown primary

    Article • European Journal of Cancer, September 2022, Elsevier

    Professor Stergios Boussios

  108. BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside

    Article • Cancers, August 2022, MDPI AG

    Professor Stergios Boussios

  109. Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer

    Article • International Journal of Environmental Research and Public Health, July 2022, MDPI AG

    Professor Stergios Boussios

  110. COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?

    Article • Journal of Personalized Medicine, July 2022, MDPI AG

    Professor Stergios Boussios

  111. Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes

    Article • International Journal of Environmental Research and Public Health, July 2022, MDPI AG

    Professor Stergios Boussios

  112. Microsatellite instability testing in colorectal patients with Lynch syndrome: lessons learned from a case report and how to avoid such pitfalls

    Article • Personalized Medicine, July 2022, Future Medicine

    Professor Stergios Boussios

  113. Sarcoma of unknown primary: myth or reality?

    Article • Journal of the Egyptian National Cancer Institute, June 2022, Springer Science + Business Media

    Professor Stergios Boussios

  114. Systematic review of the CUP trials characteristics and perspectives for next-generation studies

    Article • Cancer Treatment Reviews, June 2022, Elsevier

    Professor Stergios Boussios

  115. Applications of Proteomics in Ovarian Cancer: Dawn of a New Era

    Article • Proteomes, May 2022, MDPI AG

    Professor Stergios Boussios

  116. Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer

    Article • International Journal of Molecular Sciences, April 2022, MDPI AG

    Professor Stergios Boussios

  117. Epilepsy and Diagnostic Dilemmas: The Role of Language and Speech-Related Seizures

    Article • Journal of Personalized Medicine, April 2022, MDPI AG

    Professor Stergios Boussios

  118. Metastatic Anorectal Melanoma Presenting as Seizures: An Infrequent Culprit

    Article • Diseases, April 2022, MDPI AG

    Professor Stergios Boussios

  119. Case of cerebral venous thrombosis on a patient with background of nephrotic syndrome

    Article • BMJ Case Reports, March 2022, BMJ

    Professor Stergios Boussios

  120. Systematic review of fetal and placental metastases among pregnant patients with cancer

    Article • Cancer Treatment Reviews, March 2022, Elsevier

    Professor Stergios Boussios

  121. Non-Epithelial Ovarian Cancers: How Much Do We Really Know?

    Article • International Journal of Environmental Research and Public Health, January 2022, MDPI AG

    Professor Stergios Boussios

  122. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol

    Article • The Lancet, January 2022, Elsevier

    Professor Stergios Boussios

  123. The outcome of patients with serous papillary peritoneal cancer, fallopian tube cancer, and epithelial ovarian cancer by treatment eras: 27 years data from the SEER registry

    Article • Cancer Epidemiology, December 2021, Elsevier

    Professor Stergios Boussios

  124. BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations

    Article • International Journal of Molecular Sciences, November 2021, MDPI AG

    Professor Stergios Boussios

  125. The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next?

    Article • International Journal of Environmental Research and Public Health, October 2021, MDPI AG

    Professor Stergios Boussios

  126. Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Professor Stergios Boussios

  127. Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Professor Stergios Boussios

  128. Unraveling the Wide Spectrum of Melanoma Biomarkers

    Article • Diagnostics, July 2021, MDPI AG

    Professor Stergios Boussios

  129. Genomic correlates of response and resistance to immune checkpoint inhibitors in carcinomas of unknown primary

    Article • European Journal of Clinical Investigation, May 2021, Wiley

    Professor Stergios Boussios

  130. Aberrations of DNA repair pathways in prostate cancer: a cornerstone of precision oncology

    Article • Expert Opinion on Therapeutic Targets, May 2021, Taylor & Francis

    Professor Stergios Boussios

  131. Cancer-Associated Thrombosis: A New Light on an Old Story

    Article • Diseases, May 2021, MDPI AG

    Professor Stergios Boussios

  132. Comparative genomic characterization of melanoma of known and unknown primary

    Article • Revista de Oncología, May 2021, Springer Science + Business Media

    Professor Stergios Boussios

  133. Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities

    Article • Annals of Translational Medicine, March 2021, AME Publishing Company

    Professor Stergios Boussios

  134. Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK

    Article • Journal of Personalized Medicine, February 2021, MDPI AG

    Professor Stergios Boussios

  135. Melanoma of unknown primary: New perspectives for an old story

    Article • Critical Reviews in Oncology/Hematology, February 2021, Elsevier

    Professor Stergios Boussios

  136. Current and future immunotherapy approaches in ovarian cancer

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  137. Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  138. Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  139. Metformin and ovarian cancer: the evidence

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  140. NOTCH signalling in ovarian cancer angiogenesis

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  141. Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  142. Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  143. Ovarian cancer: state of the art and perspectives of clinical research

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  144. Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  145. Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence

    Article • Annals of Translational Medicine, December 2020, AME Publishing Company

    Professor Stergios Boussios

  146. An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer

    Article • Diagnostics, July 2020, MDPI AG

    Professor Stergios Boussios

  147. Wise Management of Ovarian Cancer: On the Cutting Edge

    Article • Journal of Personalized Medicine, May 2020, MDPI AG

    Professor Stergios Boussios

  148. Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond

    Article • Drugs in R&D, March 2020, Springer Science + Business Media

    Professor Stergios Boussios

  149. New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?

    Article • Critical Reviews in Oncology/Hematology, March 2020, Elsevier

    Professor Stergios Boussios

  150. Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach

    Article • Investigational New Drugs, October 2019, Springer Science + Business Media

    Professor Stergios Boussios

  151. Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review

    Article • Diagnostics, August 2019, MDPI AG

    Professor Stergios Boussios

  152. PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”

    Article • Diagnostics, May 2019, MDPI AG

    Professor Stergios Boussios

  153. The Developing Story of Predictive Biomarkers in Colorectal Cancer

    Article • Journal of Personalized Medicine, February 2019, MDPI AG

    Professor Stergios Boussios

  154. Ovarian carcinosarcoma: Current developments and future perspectives

    Article • Critical Reviews in Oncology/Hematology, February 2019, Elsevier

    Professor Stergios Boussios

  155. Management of Recurrent Uterine Cervical Cancer

    Article • January 2019, Springer Science + Business Media

    Professor Stergios Boussios

  156. Spinal Ewing Sarcoma Debuting with Cord Compression: Have We Discovered the Thread of Ariadne?

    Article • Anticancer Research, October 2018, International Institute of Anticancer Research

    Professor Stergios Boussios

  157. Metastatic Spinal Cord Compression: Unraveling the Diagnostic and Therapeutic Challenges

    Article • Anticancer Research, September 2018, International Institute of Anticancer Research

    Professor Stergios Boussios

  158. A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives

    Article • Journal of Advanced Research, July 2018, Elsevier

    Professor Stergios Boussios

  159. Extranodal diffuse large B-cell lymphomas: A retrospective case series and review of the literature

    Article • Hematology Reports, April 2018, MDPI AG

    Professor Stergios Boussios

  160. Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives

    Article • Annals of Gastroenterology, January 2018, Hellenic Society of Gastroenterology

    Professor Stergios Boussios

  161. Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects

    Article • Critical Reviews in Oncology/Hematology, December 2017, Elsevier

    Professor Stergios Boussios

  162. Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary

    Article • Nature Reviews Clinical Oncology, July 2017, Springer Science + Business Media

    Professor Stergios Boussios

  163. The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer

    Article • Clinical Oncology, March 2017, Elsevier

    Professor Stergios Boussios

  164. Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Professor Stergios Boussios

  165. Primary Pulmonary Malignant Melanoma: Report of an Important Entity and Literature Review

    Article • Case Reports in Oncological Medicine, January 2017, Hindawi Publishing Corporation

    Professor Stergios Boussios, Chris Kyriakopoulos

  166. Current and future biomarkers in colorectal cancer

    Article • Annals of Gastroenterology, January 2017, Hellenic Society of Gastroenterology

    Professor Stergios Boussios

  167. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review

    Article • Critical Reviews in Oncology/Hematology, December 2016, Elsevier

    Professor Stergios Boussios

  168. Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies

    Article • Anticancer Research, October 2016, International Institute of Anticancer Research

    Professor Stergios Boussios

  169. Cancer specific risk in multiple sclerosis patients

    Article • Critical Reviews in Oncology/Hematology, February 2016, Elsevier

    Professor Stergios Boussios

  170. Pancreatic resection for renal cell carcinoma metastasis: An exceptionally rare coexistence

    Article • International Journal of Surgery Case Reports, January 2016, Elsevier

    Professor Stergios Boussios

  171. Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor

    Article • Case Reports in Oncological Medicine, January 2015, Hindawi Publishing Corporation

    Professor Stergios Boussios

  172. Neuroendocrine Cell Carcinoma of Unknown Primary Arising in Long Standing History of Multiple Sclerosis

    Article • Case Reports in Oncological Medicine, January 2015, Hindawi Publishing Corporation

    Professor Stergios Boussios

  173. Lung cancer in pregnancy: Report of nine cases from an international collaborative study

    Article • Lung Cancer, December 2013, Elsevier

    Professor Stergios Boussios

  174. Renal cell carcinoma in pregnancy: a rare coexistence

    Article • Revista de Oncología, September 2013, Springer Science + Business Media

    Professor Stergios Boussios